Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS

NCT03800524 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

337

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: Tauroursodeoxycholic Acid
DRUG: Placebo

Sponsor

Humanitas Mirasole SpA

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]